Table 2.
Summary of patients’ pretreatment characteristics.
Case 1 | Case 2 | Case 3 | Case 4 | |
---|---|---|---|---|
Age (yrs) | 36 | 41 | 35 | 38 |
Body mass index (BMI) | 24.4 | 26.9 | 22.9 | 19.5 |
Diagnosis | Reduced ovarian reserve Fertility preservation |
Reduced ovarian reserve | Reduced ovarian reserve Fertility preservation |
Recurrent miscarriages |
Parity | 0/0/0/0 | 0/0/0/0 | 0/0/0/0 | 0/0/3/0 |
Blood type | 0+ | 0+ | 0+ | 0+ |
Antithrombin III % | 91 | 91 | 91 | 91.3 |
C-Protein % | 85 | 85 | 85 | 97 |
S-Protein % | 94 | 94 | 94 | 55 |
Anti-Cardiolipin IgG | Normal | Normal | Normal | Normal |
Lupus anticoagulants | Normal | Normal | Normal | Normal |
Factor V Leiden | Normal | Normal | Normal | Normal |
Factor II | Normal | Normal | Normal | Normal |
TSH | 0.87 | 2.01 | 1.62 | 1.84 |
Basal E2 (pmol/L) | 81 | 101 | 72 | 58 |
Basal FSH (IU) | 11.6 | 14.6 | 9.2 | 8.7 |
Basal P4 (nmol/L) | 0.35 | 0.24 | 0.42 | 0.37 |
Antral follicle count (AFC) | 8 | 6 | 7 | 3 |
AMH | 0.64 | 0.19 | 0.75 | 0.11 |
Vitamin D | 28 | 28 | 28 | 32 |
Abbreviations: TSH = thyroid stimulating hormone; E2 = estradiol; FSH = follicle stimulating hormone; AMH = Anti-Mullerian Hormone.